ArticleTrials2022

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.

Chawalit Lertbutsayanukul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.